Juno Therapeutics Inc is an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute. The company was launched with an initial investment of $120 million, with a remit to develop a pipeline of cancer immunotherapy drugs. The company raised $300 million through private funding and a further $265 million through their IPO. On January 22, 2018, Juno Therapeutics was acquired by biotechnology company Celgene for $9 billion. More information...
According to PR-model, junotherapeutics.com is ranked 604,932nd in multilingual Wikipedia, in particular this website is ranked 336,251st in English Wikipedia.
The website is placed before adressformona.org and after bdp.org.ar in the BestRef global ranking of the most important sources of Wikipedia.
